GlassScriptPhysician profile
Erika M Pack
NPI 1790305043
$553.70
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.24 · 2022: $106 · 2023: $65.99 · 2024: $130 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $94.52 | 2022 | |
| Pfizer INC. | $87.49 | 2025 | |
| Abbvie INC. | $69.82 | 2021-2025 | |
| Genmab U.S., INC. | $65.99 | 2023 | Tivdak |
| Hologic Sales and Service, LLC | $65.76 | 2025 | Myosure Tissue Removal Device, Omni Hysteroscope |
| Biogen, INC. | $40.71 | 2024-2025 | Zurzuvae |
| Organon LLC | $39.67 | 2024 | |
| Ethicon US, LLC | $23.93 | 2025 | Vistaseal |
| Merck Sharp & Dohme LLC | $23.09 | 2024 | Keytruda |
| Coopersurgical, INC. | $15.97 | 2024 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $14.93 | 2025 | Myfembree |
| Medtronic, INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Pack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.